Insulin and Glucagon: Partners for Life

Is glucagon essential for the hyperglycemia in insulin deficiency, as suggested by experimental glucagon antagonism? No, sufficient levels of basal insulin must be present to prevent hyperglycemia.

• Publication year

  2017

• Venue

  Endocrinology

• Publication date

  2017-01-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/en.2016-1748PMID 28323959PMCID 6061217
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucagon receptor gene deletion in insulin knockout mice modestly reduces blood glucose and ketones but does not promote survival

  2016cited by this paper
• Pancreatic α-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation

  2016cited by this paper
• Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes

  2016cited by this paper
• Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist

  2016cited by this paper
• Partners for life

  2016cited by this paper
• Evidence That in Uncontrolled Diabetes, Hyperglucagonemia Is Required for Ketosis but Not for Increased Hepatic Glucose Production or Hyperglycemia

  2015cited by this paper
• Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies

  2015cited by this paper
• Evidence of Extrapancreatic Glucagon Secretion in Man

  2015cited by this paper
• Glucagon Receptor Blockade With a Human Antibody Normalizes Blood Glucose in Diabetic Mice and Monkeys.

  2015cited by this paper
• Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway

  2015cited by this paper
• Absence of Glucagon and Insulin Action Reveals a Role for the GLP-1 Receptor in Endogenous Glucose Production

  2014influential reference
• Direct effect of GLP-1 infusion on endogenous glucose production in humans

  2012cited by this paper
• Metabolic manifestations of insulin deficiency do not occur without glucagon action

  2012cited by this paper
• Normal Glucagon Signaling and β-Cell Function After Near-Total α-Cell Ablation in Adult Mice

  2011cited by this paper
• Glucagon Receptor Knockout Prevents Insulin-Deficient Type 1 Diabetes in Mice

  2011cited by this paper
• Glucagon antagonism as a potential therapeutic target in type 2 diabetes

  2011cited by this paper
• Conversion of Adult Pancreatic α-cells to β-cells After Extreme β-cell Loss

  2010cited by this paper
• Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor.

  2010cited by this paper
• The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action.

  2009cited by this paper
• Novel glucagon receptor antagonists with improved selectivity over the glucose-dependent insulinotropic polypeptide receptor.

  2008cited by this paper
• Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.

  2006cited by this paper
• Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice.

  2004cited by this paper
• Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.

  2004cited by this paper
• Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout mice

  2003cited by this paper
• Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect.

  2003cited by this paper
• Glycemic control in mice with targeted disruption of the glucagon receptor gene.

  2002cited by this paper
• Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.

  2000cited by this paper
• Advances in non-peptide glucagon receptor antagonists.

  1999cited by this paper
• Evidence for a Major Role for Glucagon in Regulation of Plasma Glucose in Conscious, Nondiabetic, and Alloxan-Induced Diabetic Rabbits

  1996cited by this paper
• Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM

  1995cited by this paper
• Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats

  1994cited by this paper
• Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas.

  1990influential reference
• Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus.

  1987cited by this paper
• Role of Hyperglucagonemia in Maintenance of Increased Rates of Hepatic Glucose Output in Type II Diabetics

  1987cited by this paper
• Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas.

  1985cited by this paper
• Demonstration of Glucagon in the Stomach of Human Fetuses

  1981cited by this paper
• 共やくエクイン・エストロゲン(Premarin)服用閉経婦人の血清エクイリン,エストロン,エストラジオール値

  1980cited by this paper
• Hyperglucagonemia and its suppression. Importance in the metabolic control of diabetes.

  1978cited by this paper
• Extrapancreatic glucagons.

  1978cited by this paper
• Ketoacidosis in pancreatectomized man.

  1977cited by this paper
• Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon.

  1975cited by this paper
• The essential role of glucagon in the pathogenesis of diabetes mellitus.

  1975cited by this paper
• Control of Pancreatic Glucagon Secretion by Glucose

  1969cited by this paper
• Glucagon antibodies and an immunoassay for glucagon.

  1961cited by this paper
• AQUEOUS EXTRACTS OF PANCREAS III. SOME PRECIPITATION REACTIONS OF INSULIN

  1923cited by this paper

• Liver–pancreas communication in disease and drug development

  2026cites this paper
• The role of allostatic load in adverse pregnancy outcomes: a multisystem, developmental perspective

  2026cites this paper
• Clinical benefits of central pancreatectomy for a patient with pancreatic schwannoma and diabetes

  2025cites this paper
• Pancreatic Islet Cell Hormones: Secretion, Function, and Diabetes Therapy

  2025cites this paper
• The spatial distribution of endocrine cells in the pancreas of the mourning gecko (Lepidodactylus lugubris) reflects their embryonic origins

  2025cites this paper
• Glucagon in glucose homeostasis and metabolic disease: from physiology to therapeutics

  2025cites this paper
• The impact of glucagon to support postabsorptive glucose flux and glycemia in healthy rats and its attenuation in male Zucker diabetic fatty rats

  2024cites this paper
• Analysis of Glucose Responsive Glucagon Therapeutics using Computational Models of the Glucoregulatory System

  2024cites this paper
• Research advances in understanding crosstalk between organs and pancreatic β‐cell dysfunction

  2024cites this paper
• Moderate beta-cell ablation triggers synergic compensatory mechanisms even in the absence of overt metabolic disruption

  2024cites this paper
• Assessing the Catalytic Role of Native Glucagon Amyloid Fibrils.

  2024cites this paper
• Impaired plasma glucose clearance is a key determinant of fasting hyperglycemia in people with obesity

  2024cites this paper
• Glucagon 100 years. Important, but still enigmatic.

  2023cites this paper
• Retatrutide: a triple incretin receptor agonist for obesity management

  2023cites this paper
• Different post-pancreatectomy glucagon responses to a meal test between surgical approaches.

  2023cites this paper
• Fatty acid β‐oxidation and mitochondrial fusion are involved in cardiac microvascular endothelial cell protection induced by glucagon receptor antagonism in diabetic mice

  2023cites this paper
• Managing Diabetes with Hydrogel Drug Delivery

  2023cites this paper
• Chronic physiologic hyperglycemia impairs insulin-mediated suppression of plasma glucagon concentration in healthy humans.

  2023cites this paper
• High glucose-induced glucagon resistance and membrane distribution of GCGR revealed by super-resolution imaging

  2023cites this paper
• The relationship between glucose and the liver-alpha cell axis – A systematic review

  2023cites this paper
• Editorial: Beta-Cell Fate: From Gene Circuits to Disease Mechanisms

  2022cites this paper
• The past, present, and future physiology and pharmacology of glucagon.

  2022cites this paper
• Glucagon induces the hepatic expression of inflammatory markers in vitro and in vivo

  2022cites this paper
• Study of enzyme-hydrolyzed soybean replacing fish meal and/or chicken meal on the growth of channel catfish (Ictalurus punctatus)

  2022cites this paper
• Native Glucagon Amyloids Catalyze Key Metabolic Reactions.

  2022cites this paper
• The Liver–α-Cell Axis in Health and in Disease

  2022cites this paper
• Evolution of the diagnostic value of "the sugar of the blood": hitting the sweet spot to identify alterations in glucose dynamics.

  2022cites this paper
• Positive association of glucagon with bone turnover markers in type 2 diabetes: A cross‐sectional study

  2022cites this paper
• High Protein Diets Improve Liver Fat and Insulin Sensitivity by Prandial but Not Fasting Glucagon Secretion in Type 2 Diabetes

  2022cites this paper
• Distinct Dibasic Cleavage Specificities of Neuropeptide-Producing Cathepsin L and Cathepsin V Cysteine Proteases Compared to PC1/3 and PC2 Serine Proteases

  2022cites this paper
• Targeting the Pancreatic α-Cell to Prevent Hypoglycemia in Type 1 Diabetes

  2021cites this paper
• Glucose Metabolism After Pancreatectomy: Opposite Extremes Between Pancreaticoduodenectomy and Distal Pancreatectomy

  2021cites this paper
• Starvation Ketoacidosis With Hypoglycemia in a Patient With Chronic Pancreatitis

  2021cites this paper
• Glucagon blockade restores functional β-cell mass in type 1 diabetic mice and enhances function of human islets

  2021cites this paper
• Associations of Plasma Glucagon Levels with Estimated Glomerular Filtration Rate, Albuminuria and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus

  2021cites this paper
• Direct and indirect control of hepatic glucose production by insulin.

  2021cites this paper
• An Abductive Inference Approach to Assess the Performance-Enhancing Effects of Drugs Included on the World Anti-Doping Agency Prohibited List

  2021cites this paper
• Diabetes Mellitus: Disorder of Cellular Dysfunction Due to Lack of Entry into Cell of Glucose. The Most Efficient Fuel for Cellular Function*

  2021cites this paper
• Using adjuvant pharmacotherapy in the treatment of type 1 diabetes

  2021cites this paper
• Preproglucagon Products and Their Respective Roles Regulating Insulin Secretion.

  2021cites this paper
• Comparing the Antidiabetic Effects of Aqueous Extracts of Stevia rebaudiana and Gymnema sylvestre In Normal and Streptozotocin Induced Experimental Rats

  2021cites this paper
• Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin?

  2021cites this paper
• Specific reprogramming of alpha cells to insulin-producing cells by short glucagon promoter-driven Pdx1 and MafA

  2021cites this paper
• Gq signaling in α cells is critical for maintaining euglycemia

  2021cites this paper
• In Vivo Metabolic Roles of G Proteins of the Gi Family Studied with Novel Mouse Models.

  2021cites this paper
• Pancreatic Hormones

  2020cites this paper
• Spliced genes in muscle from Nelore Cattle and their association with carcass and meat quality

  2020cites this paper
• Life-Threatening Ketoacidosis in a Patient with Type 2 Diabetes Precipitated by LCHF Diet and SGLT2 Inhibition

  2020cites this paper
• The Amylin Circuit-Breaker: Restoring Glucagon Counterregulation in T1D

  2020cites this paper
• The role of α-cells in islet function and glucose homeostasis in health and type 2 diabetes.

  2020cites this paper
• Characterization of Insulin and Glucagon Genes and Their Producing Endocrine Cells From Pygmy Sperm Whale (Kogia breviceps)

  2020cites this paper
• Home‐based high‐intensity interval training reduces barriers to exercise in people with type 1 diabetes

  2020cites this paper
• Roger Harold Unger. L’homme par qui le glucagon a reçu ses lettres de noblesse

  2020cites this paper
• Glucagon Receptor Signaling and Glucagon Resistance

  2019cites this paper
• Tripartite cell networks for glucose homeostasis

  2019cites this paper
• Assessment of Islet Alpha- and Beta-Cell Function

  2019cites this paper
• Glucagon Receptor Signaling and Lipid Metabolism

  2019cites this paper
• The liver-alpha cell axis and type 2 diabetes.

  2019cites this paper
• Glucagon Receptor Antagonism Ameliorates Progression of Heart Failure

  2019cites this paper
• Glucose and amino acid metabolism in mice depend mutually on glucagon and insulin receptor signaling.

  2019cites this paper
• Health benefits of resveratrol: Evidence from clinical studies

  2019cites this paper
• Molecular and genetic regulation of pig pancreatic islet cell development

  2019cites this paper
• Carbohydrate Intake in the Context of Exercise in People with Type 1 Diabetes

  2019cites this paper
• Universitet Glucagon Receptor Signaling and Lipid Metabolism

  2019cites this paper
• Role of Peptide Hormones in the Adaptation to Altered Dietary Protein Intake

  2019cites this paper
• AAV GCG-EGFP, a new tool to identify glucagon-secreting α-cells

  2019cites this paper
• Glucagon receptor signaling in metabolic diseases.

  2018cites this paper
• Glucagon treatment in type 1 diabetes -with focus on restoring plasma glucose during mild hypoglycemia
.

  2018cites this paper
• Insulin deficiency with and without glucagon: A comparative study between total pancreatectomy and type 1 diabetes

  2018cites this paper
• Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids

  2018cites this paper
• Chemo-enzymatic synthesis of the glucagon containing N-linked oligosaccharide and its characterization.

  2018cites this paper
• Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes.

  2018cites this paper
• Problem or solution: The strange story of glucagon

  2018cites this paper
• Le glucagon : le retour du vilain petit canard

  2018cites this paper
• Time zones of pancreatic islet metabolism

  2018cites this paper
• SIRT1 activation attenuates α cell hyperplasia, hyperglucagonaemia and hyperglycaemia in STZ-diabetic mice

  2018cites this paper
• Rate of appearance of amino acids after a meal regulates insulin and glucagon secretion in patients with type 2 diabetes: a randomized clinical trial.

  2018cites this paper
• Postprandial Plasma Glucagon Kinetics in Type 2 Diabetes Mellitus: Comparison of Immunoassay and Mass Spectrometry

  2018cites this paper
• The α-cell in diabetes mellitus

  2018cites this paper
• Copeptin, a surrogate marker for arginine vasopressin secretion, is positively associated with glucagon

  2018cites this paper
• Glucose kinetics: an update and novel insights into its regulation by glucagon and GLP-1

  2017cites this paper
• Current Therapies That Modify Glucagon Secretion: What Is the Therapeutic Effect of Such Modifications?

  2017cites this paper
• Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes

  2017cites this paper